KORU Medical Systems, Inc. (KRMD)

NASDAQ: KRMD · IEX Real-Time Price · USD
3.98
-0.02 (-0.50%)
Jun 5, 2023, 1:26 PM EDT - Market open
-0.5%
Market Cap 183.71M
Revenue (ttm) 29.04M
Net Income (ttm) -8.53M
Shares Out 46.39M
EPS (ttm) -0.19
PE Ratio n/a
Forward PE 188.68
Dividend n/a
Ex-Dividend Date n/a
Volume 3,336
Open 3.99
Previous Close 4.00
Day's Range 3.96 - 4.00
52-Week Range 1.82 - 4.48
Beta 0.40
Analysts Strong Buy
Price Target 4.25 (+6.78%)
Earnings Date Aug 2, 2023

About KRMD

KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company also provides education and training materials to clinicians, patients, and patient advocates. It sells its products through direct sales... [Read more]

Sector Healthcare
Founded 1980
Employees 85
Stock Exchange NASDAQ
Ticker Symbol KRMD
Full Company Profile

Financial Performance

In 2022, KRMD's revenue was $27.90 million, an increase of 18.76% compared to the previous year's $23.49 million. Losses were -$8.66 million, 89.8% more than in 2021.

Financial Statements

Analyst Forecast

According to 2 analysts, the average rating for KRMD stock is "Strong Buy." The 12-month stock price forecast is $4.25, which is an increase of 6.78% from the latest price.

Price Target
$4.25
(6.78% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

KORU Medical Systems, Inc. Announces 2023 First Quarter Financial Results

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commerci...

1 month ago - Business Wire

KORU Medical Systems to Report First Quarter Financial Results on May 4, 2023

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercializat...

1 month ago - Business Wire

KORU Medical Systems Announces 2022 Q4 and Full Year Financial Results, Accelerating to 19% Revenue Growth in 2022

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commerci...

3 months ago - Business Wire
}

KORU Medical Systems to Report Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercializat...

3 months ago - Business Wire

KORU Medical Systems Announces Subcutaneous Immunoglobulin Prefilled Syringe Development Agreement

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical”), a leading medical technology company focused on the development, manufacturing, and commercialization of in...

4 months ago - Business Wire

KORU Medical Systems to Participate in the Piper Sandler 34th Annual Healthcare Conference

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercializ...

7 months ago - Business Wire

KORU Medical Systems to Participate in Upcoming Investor Conferences

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercializ...

7 months ago - Business Wire
}

KORU Medical Systems Joins Subcutaneous Drug Development & Delivery Consortium

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical”), a leading medical technology company focused on the development of innovative and easy-to-use home infusion s...

8 months ago - Business Wire
}

KORU Medical Systems to Participate in Canaccord Genuity's 42nd Annual Growth Conference

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of innovative and easy-to-use home...

10 months ago - Business Wire

KORU Medical Systems Announces 2022 Second Quarter Financial Results

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commerci...

10 months ago - Business Wire

KORU Medical Systems to Report Second Quarter 2022 Financial Results on August 3, 2022

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of innovative and easy-to-use home...

11 months ago - Business Wire

KORU Medical Systems Announces 2022 First Quarter Financial Results

CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manu...

1 year ago - Business Wire

KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of EMPAVELI® (pegcetacoplan), Expands European Label for FreedomEdge®

CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manu...

1 year ago - Business Wire

KORU Medical Systems to Report First Quarter 2022 Financial Results on May 4, 2022

CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of in...

1 year ago - Business Wire

KORU Medical Systems Appoints Brian Case As Chief Technology Officer

CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of in...

1 year ago - Business Wire

KORU Medical Systems Announces 2021 Q4 and Full Year Financial Results

CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manu...

1 year ago - Business Wire

CORRECTING and REPLACING KORU Medical Systems to Report Fourth Quarter and Full Year 2021 Financial Results on March 2, 2022

CHESTER, N.Y.--(BUSINESS WIRE)--First paragraph, first sentence of release dated February 16, 2022, should read: Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the ...

1 year ago - Business Wire

KORU Medical Systems to Report Fourth Quarter and Full Year 2021 Financial Results on March 2, 2021

CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of in...

1 year ago - Business Wire

KORU Medical Systems Receives FDA 510(k) Clearance for the Use of the FREEDOM60® with Two Additional SCIg Drugs

CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of in...

1 year ago - Business Wire

KORU Medical Systems to Unveil Updated Strategic Plan at Investor Day

CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development of in...

1 year ago - Business Wire